Na‐Qiong Wu

5.5k total citations · 1 hit paper
192 papers, 3.3k citations indexed

About

Na‐Qiong Wu is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Na‐Qiong Wu has authored 192 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Surgery, 79 papers in Cardiology and Cardiovascular Medicine and 65 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Na‐Qiong Wu's work include Lipoproteins and Cardiovascular Health (118 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (56 papers) and Cancer, Lipids, and Metabolism (34 papers). Na‐Qiong Wu is often cited by papers focused on Lipoproteins and Cardiovascular Health (118 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (56 papers) and Cancer, Lipids, and Metabolism (34 papers). Na‐Qiong Wu collaborates with scholars based in China, United States and Brazil. Na‐Qiong Wu's co-authors include Cheng‐Gang Zhu, Yuan‐Lin Guo, Jian‐Jun Li, Rui‐Xia Xu, Jian‐Jun Li, Ying Gao, Sha Li, Ye‐Xuan Cao, Jing‐Lu Jin and Jing Sun and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Na‐Qiong Wu

183 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Chinese guideline for lipid management

2023 81 citations Jian‐Jun Li, Yuan‐Lin Guo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Na‐Qiong Wu China	31	1.9k	1.2k	1.1k	572	483	192	3.3k
Yuan‐Lin Guo China	29	1.8k 1.0×	1.2k 1.0×	994 0.9×	534 0.9×	428 0.9×	156	3.2k
Cheng‐Gang Zhu China	31	2.0k 1.1×	1.5k 1.2×	1.2k 1.1×	629 1.1×	423 0.9×	209	3.7k
Rui‐Xia Xu China	33	1.7k 0.9×	1.0k 0.8×	714 0.7×	440 0.8×	630 1.3×	158	3.5k
G. Kees Hovingh Netherlands	30	2.1k 1.1×	1.0k 0.8×	1.3k 1.2×	298 0.5×	646 1.3×	76	3.4k
William J. Sasiela United States	21	2.9k 1.6×	1.2k 1.0×	1.0k 0.9×	585 1.0×	716 1.5×	61	3.9k
Masa‐aki Kawashiri Japan	35	2.4k 1.3×	1.5k 1.2×	1.2k 1.1×	473 0.8×	714 1.5×	286	4.6k
Pia R. Kamstrup Denmark	22	3.0k 1.6×	1.5k 1.2×	1.2k 1.1×	294 0.5×	840 1.7×	48	3.7k
Mieke D. Trip Netherlands	33	1.8k 1.0×	1.2k 1.0×	1.0k 0.9×	347 0.6×	578 1.2×	70	3.6k
Eak Kyun Shin South Korea	31	1.3k 0.7×	1.3k 1.1×	1.1k 1.0×	845 1.5×	254 0.5×	123	3.2k
Craig Granowitz United States	18	1.6k 0.9×	1.0k 0.8×	1.3k 1.2×	342 0.6×	285 0.6×	55	3.2k

Countries citing papers authored by Na‐Qiong Wu

Since Specialization

Citations

This map shows the geographic impact of Na‐Qiong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na‐Qiong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na‐Qiong Wu more than expected).

Fields of papers citing papers by Na‐Qiong Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na‐Qiong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na‐Qiong Wu. The network helps show where Na‐Qiong Wu may publish in the future.

Co-authorship network of co-authors of Na‐Qiong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Na‐Qiong Wu. A scholar is included among the top collaborators of Na‐Qiong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na‐Qiong Wu. Na‐Qiong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xi, et al.. (2025). Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine. 26(2). 25985–25985. 2 indexed citations

Li, Sha, Yan Zhang, Yan Zhang, et al.. (2025). Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary Syndrome. MedComm. 6(12). e70505–e70505.

Zhu, Cheng‐Gang, et al.. (2024). Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases. Diabetes & Metabolism Journal. 48(5). 993–1002. 5 indexed citations

Liu, Huihui, Sha Li, Yan Zhang, et al.. (2024). Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome. Journal of Atherosclerosis and Thrombosis. 31(9). 1319–1332. 1 indexed citations

Yang, Cheng, Changdong Guan, Yan-Lu Xu, et al.. (2024). Diagnostic performance of intravascular ultrasound-based fractional flow reserve in evaluating of intermediate left main stenosis. Journal of Geriatric Cardiology. 21(1). 34–43. 1 indexed citations

Wang, Yutang, et al.. (2024). Non-Fasting Plasma Triglycerides Are Positively Associated with Diabetes Mortality in a Representative US Adult Population. 2(2). 93–103. 2 indexed citations

Zhang, Yan, Na‐Qiong Wu, Song Han, et al.. (2024). Elevated Astrocytic NFAT5 of the hippocampus increases epilepsy susceptibility in hypoxic‐ischemic mice. Epilepsia. 66(3). 817–832. 2 indexed citations

Zhang, Shuang, Zheng Yin, Jian‐Jun Li, et al.. (2023). LDL‐C rebound after long‐term evolocumab treatment and intravascular imaging evidence in a familial hypercholesterolemia patient with early‐onset myocardial infarction. Chronic Diseases and Translational Medicine. 10(1). 69–74.

Liu, Huihui, Ye‐Xuan Cao, Jing‐Lu Jin, et al.. (2021). Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study. Cardiovascular Diabetology. 20(1). 84–84. 20 indexed citations

10.

Liu, Mingming, Huihui Liu, Yuan‐Lin Guo, et al.. (2021). Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study. Thrombosis Journal. 19(1). 90–90. 7 indexed citations

11.

Cao, Ye‐Xuan, Huiwen Zhang, Jing‐Lu Jin, et al.. (2020). Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease. Journal of Lipid Research. 61(9). 1254–1262. 27 indexed citations

12.

Cao, Ye‐Xuan, Huiwen Zhang, Jing‐Lu Jin, et al.. (2020). Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study. Thrombosis and Haemostasis. 121(9). 1161–1168. 16 indexed citations

13.

Wu, Na‐Qiong, Qian Dong, Qiu‐Ting Dong, et al.. (2020). LIPOPROTEIN(A), CORONARY ARTERY CALCIFICATION AND CARDIOVASCULAR EVENTS: A COHORT STUDY FROM CHINA. Journal of the American College of Cardiology. 75(11). 119–119. 1 indexed citations

14.

Gao, Ying, Na‐Qiong Wu, Chenggang Zhu, et al.. (2017). Comparision of non-fasting with fasting blood lipid testing in in-hospital patients. Zhonghua jianyan yixue zazhi. 40(6). 431–435.

15.

Yang, Shenghua, Ying Du, Yan Zhang, et al.. (2017). Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study. BMJ Open. 7(6). e015041–e015041. 23 indexed citations

16.

Li, Sha, Xiaolin Li, Cheng‐Gang Zhu, et al.. (2016). C-reactive protein as a predictor for poor collateral circulation in patients with chronic stable coronary heart disease. Annals of Medicine. 48(1-2). 83–88. 12 indexed citations

17.

Zhang, Yan, Sha Li, Rui‐Xia Xu, et al.. (2015). Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography. Mediators of Inflammation. 2015(1). 235742–235742. 12 indexed citations

18.

Wu, Na‐Qiong & Jian‐Jun Li. (2014). PCSK9 gene mutations and low-density lipoprotein cholesterol. Clinica Chimica Acta. 431. 148–153. 36 indexed citations

19.

Li, Xiaolin, Yuan‐Lin Guo, Cheng‐Gang Zhu, et al.. (2014). Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease. Lipids in Health and Disease. 13(1). 73–73. 9 indexed citations

20.

Li, Xiaolin, Jian‐Jun Li, Yuan‐Lin Guo, et al.. (2014). Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus. PLoS ONE. 9(7). e101719–e101719. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact